These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 7682810

  • 1. Estrogen and insulin modulation of intracellular insulin-like growth factor binding proteins in human breast cancer cells: possible involvement in lysosomal hydrolases oversecretion.
    Dubois V, Couissi D, Schonne E, Schneider YJ, Remacle C, Trouet A.
    Biochem Biophys Res Commun; 1993 Apr 15; 192(1):295-301. PubMed ID: 7682810
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status.
    Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D.
    J Cell Biochem; 1993 Jun 15; 52(2):196-205. PubMed ID: 7690042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated.
    Oh Y, Müller HL, Pham H, Lamson G, Rosenfeld RG.
    Growth Regul; 1993 Mar 15; 3(1):84-7. PubMed ID: 7683543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma.
    Shao ZM, Sheikh MS, Ordonez JV, Feng P, Kute T, Chen JC, Aisner S, Schnaper L, LeRoith D, Roberts CT.
    Cancer Res; 1992 Sep 15; 52(18):5100-3. PubMed ID: 1381277
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D.
    J Cell Physiol; 1993 Nov 15; 157(2):229-36. PubMed ID: 7693722
    [Abstract] [Full Text] [Related]

  • 11. IGF binding proteins and their functions.
    Clemmons DR.
    Mol Reprod Dev; 1993 Aug 15; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV.
    Cancer Res; 2001 Aug 01; 61(15):5771-7. PubMed ID: 11479214
    [Abstract] [Full Text] [Related]

  • 15. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Ryś J.
    Growth Horm IGF Res; 2005 Apr 01; 15(2):140-7. PubMed ID: 15809018
    [Abstract] [Full Text] [Related]

  • 16. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L, Fauconnet S, Lamielle F, Adessi GL.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 01; 46(7):1173-82. PubMed ID: 11075947
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.
    J Endocrinol; 2006 Dec 01; 191(3):605-12. PubMed ID: 17170218
    [Abstract] [Full Text] [Related]

  • 19. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M, Okazaki R, De León D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL.
    Proc Assoc Am Physicians; 1996 Mar 01; 108(2):155-64. PubMed ID: 8705735
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.